Sionna Therapeutics, Inc. (SION)

7.18 +0.43 (+6.37%) USD  |  NASDAQ  |  Sep 04, 16:00
7.215 +0.04 (+0.49%) After-Hours: 20:00
More

Sionna Therapeutics SG&A Expense (TTM) : 37.45M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for SION.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 37.45M
March 31, 2026 33.36M
December 31, 2025 28.72M
September 30, 2025 24.16M
June 30, 2025 16.39M
March 31, 2025 9.871M
Date Value
December 31, 2024 3.88M
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. 2.008B
ACADIA Pharmaceuticals, Inc. 620.29M
Immunic, Inc. 27.24M
Alnylam Pharmaceuticals, Inc. 1.318B
Anika Therapeutics, Inc. 52.67M